Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BDTX compared with DAVA: revenue, margins and what each company keeps, and the suppliers and customers both name
BDTX
Black Diamond Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
DAVA
Endava plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BDTX
Black Diamond Therapeutics, Inc.
vs
DAVA
Endava plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BDTX, solid
DAVA, dashed
Supply-chain overlap
Revenue flow
BDTX: latest quarter not drawable. DAVA: latest quarter not drawable.
Method
›
BDTX
Black Diamond Therapeutics, Inc.
Change
1.77
· pre 1.77
· delayed
Mkt cap
$102.3M
Revenue
$70M
Q1 FY25
DAVA
Endava plc
Change
1.60
· pre 1.60
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$175.4M
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
BDTX
Black Diamond Therapeutics, Inc.
vs
DAVA
Endava plc
1.77
pre 1.77
delayed
Price
1.60
pre 1.60
delayed
$102.3M
Mkt cap
$175.4M
Q1 FY25
$70M
Revenue
—
Change
Change
BDTX
1.77
vs
DAVA
1.60
Pre-market
Oct 30 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BDTX
3
GH
Guardant Health
supplier
—
Ivy Brain Tumor Center
unlisted
supplier
—
Servier Pharmaceuticals LLC (Servier)
unlisted
customer
Shared
0
No disclosed counterparties: DAVA.
Only DAVA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR